Literature DB >> 16982997

The cutting edge. Severe hidradenitis suppurativa treated with adalimumab.

Danielle K Moul1, Neil J Korman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982997     DOI: 10.1001/archderm.142.9.1110

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  13 in total

Review 1.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

Review 2.  An Update on Medical Treatment Options for Hidradenitis Suppurativa.

Authors:  I E Deckers; E P Prens
Journal:  Drugs       Date:  2016-02       Impact factor: 9.546

3.  A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa.

Authors:  Robert A Lee; Erica Dommasch; James Treat; Joslyn Sciacca-Kirby; Samuel Chachkin; Jennifer Williams; Daniel B Shin; James J Leyden; Carmela Vittorio; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2009-01-31       Impact factor: 11.527

4.  Successful Treatment of Recalcitrant Hidradenitis Suppurativa with Adalimumab.

Authors:  Ian Gorovoy; Adar Berghoff; Laura Ferris
Journal:  Case Rep Dermatol       Date:  2009-10-27

Review 5.  Spondyloarthritis associated with acne conglobata, hidradenitis suppurativa and dissecting cellulitis of the scalp: a review with illustrative cases.

Authors:  Debbie T Lim; Neena M James; Sobia Hassan; Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

Review 6.  Adalimumab in dermatology.

Authors:  Pawel Traczewski; Lidia Rudnicka
Journal:  Br J Clin Pharmacol       Date:  2008-07-11       Impact factor: 4.335

Review 7.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.

Authors:  Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal:  J Am Acad Dermatol       Date:  2019-03-11       Impact factor: 15.487

Review 8.  Management of cutaneous disorders related to inflammatory bowel disease.

Authors:  Zaira Pellicer; Jesus Manuel Santiago; Alejandro Rodriguez; Vicent Alonso; Rosario Antón; Marta Maia Bosca
Journal:  Ann Gastroenterol       Date:  2012

9.  Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab.

Authors:  Dubravka Bosnić; Branimir Žarković; Marko Barešić; Maja Zarkovic; Branimir Anić
Journal:  Reumatologia       Date:  2016-12-30

Review 10.  Hidradenitis suppurativa: an update on connecting the tracts.

Authors:  Mallory K Smith; Cynthia L Nicholson; Angela Parks-Miller; Iltefat H Hamzavi
Journal:  F1000Res       Date:  2017-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.